Boehringer Looks To Toss Inhaler Antitrust Case
By Matthew Perlman · July 19, 2024, 7:29 PM EDT
Boehringer Ingelheim Pharmaceuticals Inc. urged a Massachusetts federal court to toss a proposed class action accusing it of blocking generic versions of two inhaler medications, saying it has valid patents protecting...
To view the full article, register now.